Literature DB >> 30375179

Therapeutic efficacy of chlorhexidine-based mouthwashes and its adverse events: Performance-related evaluation of mouthwashes added with Anti-Discoloration System and cetylpyridinium chloride.

Fabrizio Guerra1, Debora Pasqualotto1, Francesca Rinaldo1, Marta Mazur1, Denise Corridore1, Italo Nofroni2, Livia Ottolenghi1, Gianna Maria Nardi1.   

Abstract

OBJECTIVES: To compare 3 mouthwashes: 0.20% chlorhexidine (CHX) with Anti-Discoloration System (ADS), 0.20% CHX and 0.12% CHX with 0.05% cetylpyridinium chloride (CPC), in terms of reduction of plaque and gingival bleeding and side effects.
METHODS: Mild gingivitis patients were randomly divided into three Groups: they underwent professional oral hygiene and received instructions: oral rinse with 10 mL for 1', twice a day, 30' after tooth brushing, for 14 days. Primary outcomes were plaque and gingival bleeding, assessed with Plaque Control Record and Gingival Bleeding Index. Feedback questionnaire and spectrophotometer evaluated secondary outcomes: adverse events. Timing of the study was T0 (baseline), T1 (professional oral hygiene) and T2 (14th day after mouthwash use).
RESULTS: Sixty-six patients were recruited, two patients dropped out, and 64 patients completed the study. PCR T1-T2 mean variation was 30.67 (SD = 15.22; 95% CI 23.55 to 37.80; P = 0.000), 19.93 (SD = 11.03; 95% CI 14.90 to 24.95; P = 0.000) and 16.24 (SD = 15.35; 95% CI 9.60 to 22.88; P = 0.000) respectively in Groups 0.2% CHX + ADS, 0.2% CHX and 0.12% CHX + CPC. GBI mean variation (T0-T2) was -9.82 (SD = 9.27; 95% CI -5.48 to 14.16; P = 0.000), -19.31 (SD = 11.33; 95% CI -14.15 to -24.47; P = 0.000) and -21.13 (SD = 12.56; 95% CI -15.70 to -26.56; P = 0.000) respectively in Groups 0.2% CHX + ADS, 0.2% CHX and 0.12% CHX + CPC. Statistical significance was found in lower efficacy of 0.2% CHX + ADS Group. Patients tolerated 0.12% CHX + CPC mouthwash better in bleeding perception (95.5%; P = 0.046), burning sensation (13.6%; P = 0.006), and mouthwash taste (100%; P = 0.000). Results on staining were no statistically significant (P = 0.106).
CONCLUSIONS: Addition of CPC allows reduction of CHX percentage in mouthwash formulation while keeping equal efficacy and less side effects. ADS addition decreases CHX efficacy in reducing plaque and bleeding, while resulting more tolerated than CHX.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Anti-Discoloration System; cetylpyridinium chloride; chlorhexidine digluconate; mouthwash

Mesh:

Substances:

Year:  2019        PMID: 30375179     DOI: 10.1111/idh.12371

Source DB:  PubMed          Journal:  Int J Dent Hyg        ISSN: 1601-5029            Impact factor:   2.477


  12 in total

1.  Early Response and Clinical Efficacy of a Mouthwash Containing Chlorhexidine, Anti Discoloration System, Polyvinylpyrrolidone/Vinyl Acetate and Sodium DNA in Periodontitis Model: A Triple-Blind Randomized Controlled Clinical Trial.

Authors:  Felice Lorusso; Gianluca Tartaglia; Francesco Inchingolo; Antonio Scarano
Journal:  Dent J (Basel)       Date:  2022-06-07

2.  Effect of Citrus aurantium L. Essential Oil on Streptococcus mutans Growth, Biofilm Formation and Virulent Genes Expression.

Authors:  Chahrazed Benzaid; Amine Belmadani; Lazhari Tichati; Ryad Djeribi; Mahmoud Rouabhia
Journal:  Antibiotics (Basel)       Date:  2021-01-08

3.  Cannabinoids infused mouthwash products are as effective as chlorhexidine on inhibition of total-culturable bacterial content in dental plaque samples.

Authors:  Kumar Vasudevan; Veronica Stahl
Journal:  J Cannabis Res       Date:  2020-06-23

Review 4.  Recent Development of Active Ingredients in Mouthwashes and Toothpastes for Periodontal Diseases.

Authors:  Meenakshi Rajendiran; Harsh M Trivedi; Dandan Chen; Praveen Gajendrareddy; Lin Chen
Journal:  Molecules       Date:  2021-04-01       Impact factor: 4.411

5.  The Effect of Chlorhexidine Disinfectant Gels with Anti-Discoloration Systems on Color and Mechanical Properties of PMMA Resin for Dental Applications.

Authors:  Zbigniew Raszewski; Danuta Nowakowska; Włodzimierz Więckiewicz; Agnieszka Nowakowska-Toporowska
Journal:  Polymers (Basel)       Date:  2021-05-29       Impact factor: 4.329

6.  Influence of Tooth-Brushing on Early Healing after Access Flap Surgery: A Randomized Controlled Preliminary Study.

Authors:  Carlo Bertoldi; Luigi Generali; Pierpaolo Cortellini; Michele Lalla; Sofia Luppi; Aldo Tomasi; Davide Zaffe; Roberta Salvatori; Stefania Bergamini
Journal:  Materials (Basel)       Date:  2021-05-29       Impact factor: 3.623

7.  Combination of toothbrushing and chlorhexidine compared with exclusive use of chlorhexidine to reduce the risk of ventilator-associated pneumonia: A systematic review with meta-analysis.

Authors:  Pedro Urquiza Jayme Silva; Luiz Renato Paranhos; Daniela Meneses-Santos; Cauane Blumenberg; Dhiancarlo Rocha Macedo; Sérgio Vitorino Cardoso
Journal:  Clinics (Sao Paulo)       Date:  2021-06-11       Impact factor: 2.365

8.  Alveolar iodine tampon packing after impacted third molar surgery improves oral health-related quality of life and postoperative sequela: a randomized study.

Authors:  Jerome A Lindeboom; Jacco G Tuk; Patrick Möllenkamp; Arjen J van Wijk
Journal:  Oral Maxillofac Surg       Date:  2020-08-29

9.  Does chlorhexidine mouthwash, with an anti-discoloration system, reduce tooth surface discoloration without losing its efficacy? A systematic review and meta-analysis.

Authors:  Bregje W M Van Swaaij; G A Fridus van der Weijden; Eric W P Bakker; Filippo Graziani; Dagmar E Slot
Journal:  Int J Dent Hyg       Date:  2019-08-01       Impact factor: 2.477

10.  A Phthalocyanine Derivate Mouthwash to Gargling/Rinsing as an Option to Reduce Clinical Symptoms of COVID-19: Case Series.

Authors:  Bernardo da Fonseca Orcina; Fabiano Vieira Vilhena; Rodrigo Cardoso de Oliveira; Lucas Marques da Costa Alves; Koiti Araki; Sérgio Hiroshi Toma; Mariana Schutzer Ragghianti Zangrando; Paulo Sérgio da Silva Santos
Journal:  Clin Cosmet Investig Dent       Date:  2021-02-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.